EFX Sports LYZME-5
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Tyrosine | 83.33 mg | Not calculated |
| Folate | 0.333 mg | Not calculated |
| 3,7-diméthylxanthine | 53.33 mg | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus limon - Fruit | 8.33 mg | Not calculated |
| Niacine | 9.99 mg | Not calculated |
| 2-hydroxy-N,N,N-triméthyléthanaminium | 323.33 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Dioxyde de titane, Rouge FD&C N° 40, Gélatine, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 day |
Uses authorised in Canada
Workout supplement Athletic support Helps temporarily to promote alertness and wakefulness and to enhance cognitive performance when used occasionally Helps temporarily to relieve fatigue, to promote endurance and to enhance motor performance when used occasionally Source of amino acid involved in muscle protein synthesis Helps to support liver function A factor in the maintenance of good health Traditionally used in Herbal Medicine to aid digestion and to help support peripheral circulation Helps the body to metabolize nutrients. Helps normal growth and development Helps the body to metabolize proteins Helps to form red blood cell.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome) Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended This product is not intended as a substitute for sleep Consult a health care practitioner prior to use if you are following a low protein diet Ensure to drink enough fluid before, during, and after exercise. If symptoms persist or worsen, consult a health care practitioner. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Product record
- Other names
- EFX LYZME, LYZME 5
- Licence holder
- All American Pharmaceuticals
- NPN or DIN-HM
- 80089100
- Status
- Active licence
- Licence date
- 8 November 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80089100
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.